Lymphoblastic Lymphoma—An Overview Bookmark

Overview from Medscape curated by Contributing Editor George Lundberg, MD, who notes:

This 2019 comprehensive presentation of lymphoblastic (precursor B-cell and T-cell) lymphoma emphasizes lymph node-predominant involvement in this blood-lymph node diaspora. (Free registration required, written with a physician audience in mind.)

.

Hodgkin Lymphoma—An Overview Bookmark

Overview from Medscape curated by Contributing Editor George Lundberg, MD, who notes:

This 2020 encyclopedic approach to a potentially curable form of lymphoma is richly detailed and specific for all types and stages of Hodgkin lymphoma. (Free registration required, written with a physician audience in mind.)

.

NCCN Guidelines for Patients: Acute Myeloid Leukemia Bookmark

PDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes: 

The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about acute myeloid leukemia.

Go to full document published by the NCCN.

.

Novel Developments in the Multimodality Treatment of Esophageal Cancer Bookmark

A special issue of the research journal Annals of Esophagus curated by Contributing Editor George Lundberg, MD.

This special issue of an academic research journal discusses “multimodality” treatment—the combination of more than one treatment—and how it is used to treat advanced esophageal cancer.

.

Innovent Biologics’s TYVYT/Byvasda combo shows survival benefit in late-stage liver cancer study Bookmark

Article from Seeking Alpha curated by Contributing Editor George Lundberg, MD, who notes: 

In a phase 3 clinical trial, a new drug combination improved both overall survival and progression-free survival for people with hepatocellular carcinoma.

.

Preliminary Results of Two Large Immune Therapy Studies Show Promise in Advanced Cervical Cancer Bookmark

Press release from Ohio State University Wexner Medical Center curated by Contributing Editor George Lundberg, MD.

This press release outlines promising preliminary results from two phase 2 clinical trials testing the drug balstilimab alone or in combination with zalifrelimab.

.

Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer Bookmark

Research paper from JAMA Network Open curated by Contributing Editor George Lundberg, MD, who notes: 

This study linked continued opioid use after breast cancer treatment to many serious adverse effects in older women.

.

Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer Bookmark

Research paper from JAMA Oncology curated by Contributing Editor George Lundberg, MD, who notes: 

This study linked coffee consumption with longer survival and lower death rates in advanced colorectal cancer.

.

First Approval of Second-Line Therapy for DLBCL Bookmark

Article from MedPage Today curated by Contributing Editor George Lundberg, MD, who notes: 

The FDA has granted accelerated approval to tafasitamab (brand name Monjuvi) as a second-line therapy for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), based upon overall responses seen in a clinical trial. This is the first FDA approval of a second-line treatment for this condition. There are few, if any, other options.

.

Oral Azacitidine Wins FDA Approval for AML Bookmark

Article from MedPage Today curated by Contributing Editor George Lundberg, MD, who notes: 

The U.S. Food and Drug Administration (FDA) has approved oral azacitidine (brand name Onureg) based on clinical trial results showing a 10-month improvement in overall survival for patients with acute myeloid leukemia who are ineligible for transplant.

.